New defibrillation strategy could enhance survival rates in cardiac arrest

Joshua Lupton, M.D., has no memory of his own cardiac arrest in 2016. He only knows that first responders resuscitated his heart with a shock from a defibrillator, ultimately leading to his complete recovery and putting him among fewer than one in 10 people nationwide who survive cardiac arrest outside of a hospital.

Catalent touts GLP-1 manufacturing; Telix grows radiopharma capacity; Arcturus expands in Japan: #JPM24

Catalent’s stock $CTLT rose to the highest it’s been in three months on Tuesday after CEO Alessandro Maselli emphasized the CDMO’s big picture plan to

January 11, 2024

Key House panel proposes lowering out-of-pocket drug costs in Medicare

WASHINGTON — A key House committee announced its own plans to increase health care transparency and reduce some health care costs for patients on Monday,

July 24, 2023

J&J psoriasis drug licensed from Protagonist doesn’t top competition in Phase IIb trial

Johnson & Johnson’s oral IL-23 that it licensed from Protagonist Therapeutics appears to be a weaker psoriasis treatment than some of its injectable competition, according

July 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.